Bibliografia UJ CM

1/2
W[ojciech] Jurczak, J[oanna] Wegrzyn, A. Giza, D[orota] Krochmalczyk, B[eata] Stella-Holowiecka, A[leksandra] Holowiecka-Goral, M[onika] Swierczynska, J. Walewski, G. Mazur, T. Wrobel, E. Kalinka-Warzocha, P. Boguradzki, E. Kisiel, P. Centkowski, W[anda] Knopinska-Posluszny, T. Gromek, J. Smok-Kalwat, A[leksander] B. Skotnicki.
Role of rituximab in the first line therapy of high risk DLBCL - a Polish Lymphoma Research Group (PLRG) retrospective multicenter analysis.
Annals of Oncology
2008 : Vol. 19 suppl. 4, s. 219, abstr. 466
10th International Conference on Malignant Lymphoma, Lugano, Switzerland, 4-7 June 2008.
SZZ
SIF
2/2
W[ojciech] Jurczak, A. Giza, D[orota] Krochmalczyk, J[oanna] Węgrzyn, A[leksander] B. Skotnicki, J. Czyż, W[anda] Knopińska-Posłuszny, A. Hellmann, B. Ceglarek, P. Centkowski, A. Sikorska, K. Warzocha.
Complete remission achieved after the first line chemoimmunotherapy (HyperCVAD-MA-R) is a single most important predictive factor for overall survival in Mantle Cell Lymphoma patients. Results of multi-center Polish Lymphoma Research Group study.
Polish Journal of Environmental Studies
2005 : Vol. 14 suppl. 2, s. 569-573, il., bibliogr. 9 poz., abstr.
AP
ORG
AIF
IF: 0.352
Wyświetl ponownie stosując format: